Introduction
Polycystic ovary syndrome (PCOS) is a syndrome in which the etiology is still unclear even today. This syndrome is considered to be primarily a functional disorder of the ovary and many theories and mechanisms have been put forward on its causes to date [1] . The most popular theory of the pathophysiology of PCOS is insulin resistance [2] . Great progress has been made in this regard by molecular and clinical studies, but some questions still need answers. If the underlying cause in the pathophysiology of PCOS is insulin resistance, what is the reason for this insulin resistance? Why can insulin resistance not be shown in every case? Is there a preventive treatment? Other important factors are thought to play a role in the pathophysiology of PCOS besides insulin resistance. These factors are closely related to insulin, because even though insulin resistance cannot be demonstrated in typical PCOS cases, the therapeutic use of insulin sensitizers (metformin, rosiglitazone) provides improvements in androgen levels and ovulation [3] . This is theoretically explained by a factor that causes insulin resistance but prevents compensatory hyperinsulinism. That is, the same reason has to play a role in both the synthesis phase and the effect phase of insulin. There is increasing evidence that vitamin D affects insulin and glucose metabolism, and a low vitamin D status is suspected to be a risk factor for impaired glucose tolerance and insulin resistance [4] , but there is no evidence to suggest that there is a relationship between vitamin A, vitamin B 12 , vitamin C, folate, zinc (Zn) and PCOS in the literature. In the current study, we examined whether a low vitamin A, vitamin B 12 , vitamin C, vitamin D, folate and zinc status can be observed in Turkish women with PCOS. In addition, we investigated the relationship between serum vitamin A, vitamin B 12 , vitamin C, vitamin D, folate and zinc concentration and metabolic or clinical profiles of PCOS.
Material and methods
This study was performed on 132 women, 65 patients with PCOS and 67 healthy individuals, during 2015-2016. The study was planned as prospective, controlled and single centered and was approved by the ethics committee of our university. All women in the 16-44 age group (reproductive age) were recruited from our clinic in Turkey. According to the revised Rotterdam diagnostic criteria, PCOS was defined by the presence of at least 2 out of the following 3 features: oligo-anovulation (menstrual cycle length > 45 days or less than 6 menstrual cycles a year), clinical or biochemical hyperandrogenism (Ferriman-Gallwey (FG) score > 8 or elevated serum testosterone levels), and polycystic ovaries on transvaginal ultrasonography (TVUSG) (enlarged ovaries with increased stromal volume and more than 10 follicles which measure 2-8 mm in diameter and localize along the periphery of the ovary in a way to form 'a pearl necklace' appearance). Thyroid functions, luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2), prolactin, and total and free testosterone were assessed in patients with PCOS and control subjects, and those with thyroid diseases, hyperprolactinemia, Cushing's disease, or congenital adrenal hyperplasia and those who were administered agents such as hormonal agents, ovulation-inducing agents, glucocorticoids, anti-androgens, or anti-hypertensives over the last 6 months prior to the study were excluded from the study. A healthy woman was defined as a woman in reproductive age with regular cycles. They came to our clinic for an annual check-up. Women with congenital adrenal hyperplasia, hyperprolactinemia, hyperparathyroidism, and androgen secretory tumors were excluded using specific laboratory tests. Furthermore, women who used medications suspected to affect carbohydrate metabolism or Zn/vitamin concentrations during 6 months prior to the study, who had a history of chronic disease or endocrinopathies, and who had a history of smoking or drug abuse were excluded.
Clinical assessment
The hirsutism score was calculated according to the FG score system. Nine anatomic regions were assessed on a 4-point scale where 0 meant no growth of terminal hair and 4 meant maximum hair growth. Scores below 8 were regarded as normal and scores between 8 and 36 were regarded as pathological. Scores rose in parallel to the severity of hirsutism [5] . In addition to family history of metabolic disorders, a detailed history including menstrual cycle pattern, temporal or situated in the temples of the head profile, severity of unwanted hair growth, and drug intake was taken at the time of enrollment. Clinical examination included measurement of body weight (kg), height (cm) as well as FG scoring. FG scoring was done by a single observer, and scores above 8 were taken as significant. A single observer performed transabdominal or transvaginal ultrasonography to reveal findings of polycystic ovarian morphology (presence of at least 10 follicles around the ovary that measure 2-8 mm in size, with increased ovarian volume and/or echogenic ovarian stroma) [6] .
Laboratory tests
Blood samples were taken from the patients at the early follicular phase (between the third and the fifth days of the spontaneous or gestagen-induced menstrual cycle). Venous blood was taken from the forearm between 8.00 and 10.00 am after 8 h of fasting. Blood samples were immediately centrifuged, and sera were kept at -80°C until laboratory testing.
Vitamin B 12 , vitamin D, folate, follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol 2 (E 2 ), prolactin, total testosterone, and insulin levels were determined by electrochemiluminescence immunoassay using Acridinium Ester technology (SIEMENS CENTAUR XP, USA). Free testosterone levels were determined by the ELISA method (DiaMetra, Milano Italy). Fasting glucose and Zn levels were determined spectrophotomet-rically (OLYMPUS AU 2700, USA). C-reactive protein (CRP) was measured by the nephelometric method (SIEMENS BN II, USA). Vitamin A, vitamin C and HbA 1c levels were measured by high performance liquid chromatography (HPLC) (ADAMS ARKRAY A 10). The homeostasis model assessment of insulin resistance (HOMA-IR) was used to evaluate insulin resistance, using the following formula: HOMA-IR = (fasting plasma glucose (mg/dl) × insulin (U/ml)/405) [7] . Patients with HOMA-IR levels above 2.5 were considered to have insulin resistance (IR) [8] .
Statistical analysis
Statistical Package for the Social Sciences (SPSS 22.0) was used for data analyses. Data are expressed as mean and standard deviation. T test and nonparametric Mann-Whitney U test were used for comparison of clinical and biochemical data between the groups. Whether intra-group variables demonstrated a normal distribution or not was determined by the Kolmogorov-Smirnov test. Spearman's correlation and Pearson test analysis was used for investigation of correlations between the values. P-value < 0.05 was accepted as significant. 
Results
A total of 132 cases were evaluated: 65 in the patient group and 67 in the control group.
The metabolic and hormonal characteristics of women with PCOS and the control group are presented in Table I . The PCOS patients had higher hirsutism scores, and there were significant differences in the levels of fasting insulin and HOMA-IR between women with PCOS and the control group.
Women with PCOS showed decreased serum levels of vitamin A compared with the control group, but they showed no differences in the levels of 25-(OH)D 3 , vitamin B 12 , vitamin C, folate or Zn. The correlations between serum vitamin A, vitamin B 12 , vitamin C, vitamin D, folate, Zn and clinical or metabolic profiles in both PCOS patients and the control group are presented in Table II .
Discussion
The PCOS is characterized by ovarian androgen excess and infertility. Recent experiments have suggested that several genes involved in retinoic acid synthesis may be differentially expressed in PCOS theca cells and may contribute to excessive theca-derived androgen production. For this reason, it is very important to investigate expression levels of genes encoding proteins involved in this complex system. In a study by Wood et al. the expression of genes involved in retinoic acid biosynthesis was found to be increased in theca cells from women with PCOS [9] . All-trans retinoic acid (atRA) is a lipid that is essential for the normal function of somatic cells in male and female gonads. Studies have shown that the PCOS cases have more atRA conversion in the theca cells. The overexpression of atRA synthase causes CYP11A1 and CYP17 gene expression in the theca cells. atRA also regulates cell division and differentiation. For this reason, increased levels of atRA are also associated with arresting follicle growth [10] . In another study, it was reported that differential responses to retinol and retinoids in normal and PCOS theca suggest that altered retinoic acid synthesis and action may be involved in augmented CYP17 gene expression and androgen production in PCOS [11] . Therefore we investigated whether vitamin A (retinol) levels are related to PCOS. Our study found differences in the absolute level of serum vitamin A and prevalence of vitamin A insufficiency between women with PCOS and matched controls. Vitamin A insufficiency was observed in 18.46% of the PCOS group and 2.98% of the control group. On the other hand, we did not find any correlations between serum vitamin A and hormonal or metabolic profiles in either PCOS patients or controls (Table II) .
It has been previously demonstrated that folate and vitamin B 12 treatment improved insulin resistance in patients with metabolic syndrome [12] . Kaya et al. been reported that insulin resistance, obesity, and elevated homocysteine were associated with lower serum vitamin B 12 concentrations in PCOS patients [13] . Our study found no differences in the absolute level of serum vitamin B 12 and folate between women with PCOS and matched controls, but we found negative correlations between serum folate and fasting insulin, HbA 1c , and vitamin C levels (Table II) . Our findings suggest that the role of vitamin B 12 and folate in the pathogenesis of PCOS is not yet clear.
Oxidative stress may play a role in the pathophysiology of PCOS. Insulin resistance (IR) also can be found in young non-obese women with PCOS. Hyperglycemia may increase reactive oxygen species production and decrease antioxidant levels [14] . The association of vitamin C, a well-known anti-oxidant, with PCOS has been shown in several studies in the literature [14, 15] . Our study found no differences in the absolute level of serum vitamin C between women with PCOS and matched controls, but we found negative correlations between vitamin C levels and folate, fasting insulin and HOMA-IR (Table II) .
Increasing evidence suggests that vitamin D might have a regulatory role in PCOS-associated symptoms, including ovulatory dysfunction, insulin resistance and hyperandrogenism [16] . Therefore, the search for an association between PCOS and vitamin D metabolism appears to be justified. Vitamin D level was found to be lower in PCOS patients than the control group in the majority of the studies [17, 18] . Our study found no difference in the absolute level of serum vitamin D between women with PCOS and matched controls (Table II) .
Zn is an essential trace element and acts as a catalytic, structural and regulatory ion. At the same time, Zn has a very important role in the synthesis, storage and the potentialization of insulin, and it also plays a role as an antioxidant [19] . We assessed the association between zinc and PCOS in our study. There was no differences in the absolute level of serum zinc between women with PCOS and matched controls (Table II) .
In conclusion, the serum levels of vitamins A, B 12 , C, and D and Zn may change in patients with PCOS. The findings in this study should be investigated with further trials in order to obtain new insights into PCOS.
